tiprankstipranks
Trending News
More News >
Capricor Therapeutics (CAPR)
NASDAQ:CAPR

Capricor Therapeutics (CAPR) Similar Stocks

Compare
923 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Capricor Therapeutics
$9.29
$405.61M
49.12%
5 Buy
0 Hold
0 Sell
Strong Buy
Akebia Therapeutics
$1.65
$404.91M
7.84%
4 Buy
0 Hold
0 Sell
Strong Buy
Theravance Biopharma
$8.40
$415.06M
-12.59%
1 Buy
2 Hold
0 Sell
Moderate Buy
Mind Medicine
$6.30
$387.39M
-47.02%
9 Buy
0 Hold
0 Sell
Strong Buy
Keros Therapeutics
$12.18
$494.05M
-80.32%
8 Buy
4 Hold
0 Sell
Moderate Buy
Tyra Bioscience
$7.96
$400.83M
-47.18%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CAPR
Capricor Therapeutics
9.29
3.43
58.53%
AKBA
Akebia Therapeutics
1.65
0.26
18.71%
TBPH
Theravance Biopharma
8.40
-1.52
-15.32%
MNMD
Mind Medicine
5.43
-4.35
-44.48%
KROS
Keros Therapeutics
12.18
-45.50
-78.88%
TYRA
Tyra Bioscience
7.96
-6.79
-46.03%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis